Open AccessChoroidal Osteoma with Choroidal Neovascular Membrane treated with Anti- vascular Endothelial Growth Factor: A Rare Case with Review of Literatures
Author(s) -
Phuntsho Dorji,
Nor Tshering Lepcha,
Raba Thapa
Publication year - 2021
Publication title -
nepalese journal of ophthalmology
Language(s) - English
Resource type - Journals
eISSN - 2091-0320
pISSN - 2072-6805
DOI - 10.3126/nepjoph.v13i2.33218
Subject(s) - medicine , fundus fluorescein angiography , choroid , ophthalmology , bevacizumab , fluorescein angiography , osteoma , fundus (uterus) , choroidal neovascularization , radiology , surgery , retinal , retina , chemotherapy , physics , optics
Choroidal osteoma, usually unilateral, is a rare benign tumor of choroid. It is predominantly seen in young females. Case: We report a case of a 35-year-old female with unilateral choroidal osteoma associated with choroidal neovascular membrane (CNVM). The diagnosis was confirmed with clinical examination, ocular ultrasonography, fundus fluorescein angiography and macular optical coherence tomography. Choroidal neovascular membrane improved with 3 doses of bevacizumab, an anti-vascular endothelial growth factors (Anti-VEGF).Conclusion: Anti-VEGF monotherapy can be a cost effective primary modality of treatment for choroidal neovascular membrane secondary to choroidal osteoma.